New cancer immunotherapy recruits help from lymphatic vessels
Immunotherapy, which recruits the body’s own immune system to attack cancer, has given many cancer patients a new avenue to
Read more
New recommendations for addressing disparities in cancer care
New recommendations co-developed by Dana-Farber Cancer Institute call for a significant expansion of the National Cancer Institute (NCI) and NCI-designated
Read more
Lymph node collection kit may improve long-term survival after lung cancer surgery
A lymph node collection kit can help surgeons attain compete resection and improve long-term survival after curative-intent lung cancer surgery,
Read more
Study finds two drugs capable of slowing bone marrow cancer progression
Primary myelofibrosis (PMF), a relatively rare but painful type of bone marrow cancer, disrupts the body's normal production of blood
Read more
Maintaining body weight won’t save colorectal cancer survivors
Colorectal cancer survivors who maintained a stable body weight but lost muscle and developed fatty deposits in their muscles faced
Read more
Why Are So Few Black People Included in Cancer Drug Trials?
Researchers found that clinical trials conducted largely outside the United States were much less likely to enroll Black participants. On
Read more
A combination of family history and genomic screening provides best method of assessing cancer risk
Clinicians have historically used family health history collection as a primary method for identifying actionable disease-risk assessments. However, as large-scale
Read more
Study: Reduced activity of specific enzyme leads to much higher cancer rates
In the past few years, several medications have been found to be contaminated with NDMA, a probable carcinogen. This chemical,
Read more
New approach may lead to novel treatments for renal fibrosis
Aging is a common factor in many diseases. So, what if it were possible to treat them by acting on
Read more
Whole-Genome Sequencing Emerging for Routine Cancer Care
Almost 20 years after the human genome was first mapped, whole-genome sequencing might finally be ready to enter routine cancer
Read more